Ethics, Policy & Law
Overcoming the reimbursement barriers for clinical sequencing.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_tDi6j3k1p9CW3fwK58dJOPh4DhoUIQdEpD6QLKRpbGfeyOoCdYuNJ4Q3hIkmLykwG84cPR6CyxqinRxLL1zVRDPslVF8hxbk6iIx_2XaNoKxQ_Hl9wC8zI=s0-d)
Deverka PA, et al. JAMA 2014 Nov 12;312(18):1857-1858.
Deverka PA, et al. JAMA 2014 Nov 12;312(18):1857-1858.
Medical ethics experts outline strategy for overcoming reimbursement barriers for clinical genome sequencing tests,
Medical Xpress, Nov 11
Redefining genomic privacy: Trust and empowerment
Y Erlich et al. PLOS Biology, November 4, 2014
Y Erlich et al. PLOS Biology, November 4, 2014
Should life insurers have access to genetic test results?
Klitzman R, et al. JAMA 2014 Nov;312(18):1855-6
Klitzman R, et al. JAMA 2014 Nov;312(18):1855-6
The first FDA marketing authorizations of next-generation sequencing technology and tests: challenges, solutions and impact for future assays
Bijwaard K, et al. Expert Rev Mol Diagn 2014 Nov:1-8
Bijwaard K, et al. Expert Rev Mol Diagn 2014 Nov:1-8
Gene patents pose challenge to doctors treating genetic disorders,
Genetic Literacy Project , Nov 4
No hay comentarios:
Publicar un comentario